CHRONIC kidney disease (CKD) affects approximately 700 million individuals worldwide. Many patients with CKD require haemodialysis, and more than two-thirds of these patients have CKD-associated pruritus (CKD-aP). CKD-aP can be bothersome for many patients and drastically affect quality of life, from causing sleep issues to mental health problems. Almost 40% of dialysis patients are at least ‘moderately’ bothered and 19% of patients are at least very much bothered by pruritus.
EMJ Nephrology 9 [Supplement 4] . 2021
November 2021
In this issue
Latest articles
All articles![](https://www.emjreviews.com/wp-content/uploads/2024/07/Immune-Complex-Mediated-Web-940x564.jpg)
![](https://www.emjreviews.com/wp-content/uploads/2024/07/Challenges-in-Renal-Replacement-Therapy-in-Resource-limited-Settings-Web-940x564.png)
![](https://www.emjreviews.com/wp-content/uploads/2024/07/End-Stage-Renal-Disease-and-Neurological-Connection-Web-940x564.jpg)
![](https://www.emjreviews.com/wp-content/uploads/2024/04/Rostaing-thumbnail-940x564.png)